Delivery Order SPE2DB24D1201-SPE2DB25FJEFJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $742,596.96 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance, leveraging the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $39,010.77 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,084.96 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $23,564.75 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $44,381.09 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion targeted for August 12, 2025. This competitive, non-set-aside award reflects firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $2,819.97. The contract, designated as a firm fixed price delivery order, was competitively awarded without set-aside provisions and is scheduled for completion by September 8, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $22,859.06 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of May 28, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,386.62 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition to the most...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,468.29 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This is a firm fixed price delivery order with a completion date of September 26, 2025, issued on September 25, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill the order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $17,745.69 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract, issued on September 4, 2025, with a completion date of September 5, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from its corporate office...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEFJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, valued at $16,433.26. The contract was competitively awarded without set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform fulfillment from its Pennsylvania location. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle provides comprehensive pharmaceutical support globally, enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill competitive procurements across multiple therapeutic domains, supporting critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 9/16/25 |